West Pharmaceutical Services announced that it completed an $80 million capacity expansion at a contract manufacturing site in Michigan. The investment extends production and accessibility for patient-centric diabetes and obesity products at the Grand Rapids facility. It comes in response to increasing demand from West’s customers for device and drug delivery manufacturing solutions to support…

West Pharmaceutical Services (NYSE:WST) shares dipped slightly despite third-quarter results that topped the consensus forecast. The Exton, Pa.-based company posted profits of $82.3 million, or $1.09 per share, on sales of $548 million for the three months ended Sept. 30, 2020, for a 46.2% bottom-line gain on sales growth of 0.3%. Get the full story at…